Table 1.
All referrals | Did not re-contact | Re-contacts <30 days | Re-contacts <7 days | Re-contacts <3 days | |
Total figures | 169 | 139 (82.25%) | 30 (17.75%) | 13 (7.69%) | 7 (4.14%) |
Clinician-led referrals 15 (3–21) | 125 | 106 (84.80%) | 19 (15.20%) | 8 (6.40%) | 5 (4.00%) |
Transport refusals 12 (4–17) | 44 | 33 (75.00%) | 11 (25.00%) | 5 (11.36%) | 2 (4.55%) |
Type 1 9 (4–19) | 47 | 37 (78.72%) | 10 (21.28%) | 5 (10.64%) | 1 (2.13%) |
Type 2 18 (12–24) | 16 | 9 (56.25%) | 7 (43.75%) | 1 (6.25%) | 1 (6.25%) |
IDDM 12 (4–19) | 151 | 124 (82.11%) | 27 (17.88%) | 12 (7.95%) | 6 (3.97%) |
NIDDM 18 (1–21) | 9 | 6 (66.66%) | 3 (33.33%) | 1 (11.11%) | 1 (11.11%) |
Sulphonylureas Insufficient data | 6 | 4 (66.66%) | 2 (33.33%) | 0 (0.00%) | 0 (0.00%) |
Notes: Figures (in bold) re-contact median days (interquartile range); and n = (%).